Literature DB >> 34936120

OMICRON (B.1.1.529): A new SARS-CoV-2 variant of concern mounting worldwide fear.

Vikram Thakur1,2, Radha Kanta Ratho2.   

Abstract

Recent emergence of the SARS-CoV-2 variant as OMICRON has become a global concern. This short note highlights the identification and global spread of OMICRON which has spread over 77 nations by now, which resulted in many hypotheses about its origin and degree of infectivity. The detection of mutations in the RBD region of Spike protein is a concern by surpassing vaccine immunity. The ahead will speak about its transmission potentiality, infectivity, disease morbidity as well as its effect on COVID-19 vaccines.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  OMICRON; re-infection; spike protein; transmission; travel restrictions; vaccines

Mesh：

Substances：

Year:  2021        PMID： 34936120     DOI： 10.1002/jmv.27541

Source DB:  PubMed          Journal:  J Med Virol        ISSN： 0146-6615            Impact factor:   2.327


  54 in total

1.  Multi-Faceted Analysis of COVID-19 Epidemic in Korea Considering Omicron Variant: Mathematical Modeling-Based Study.

Authors:  Youngsuk Ko; Victoria May Mendoza; Renier Mendoza; Yubin Seo; Jacob Lee; Jonggul Lee; Donghyok Kwon; Eunok Jung
Journal:  J Korean Med Sci       Date:  2022-07-04       Impact factor: 5.354

Review 2.  Emergence of SARS-CoV-2 New Variants and Their Clinical Significance.

Authors:  Hitesh Singh; Nisha Dahiya; Mahima Yadav; Neelam Sehrawat
Journal:  Can J Infect Dis Med Microbiol       Date:  2022-05-28       Impact factor: 2.585

Review 3.  Surveillance of omicron variants through wastewater epidemiology: Latest developments in environmental monitoring of pandemic.

Authors:  Vatika Soni; Shilpa Paital; Pankaj Raizada; Tansir Ahamad; Aftab Aslam Parwaz Khan; Sourbh Thakur; Pardeep Singh; Chaudhery Mustansar Hussain; Swati Sharma; Ashok Kumar Nadda
Journal:  Sci Total Environ       Date:  2022-06-15       Impact factor: 10.753

Review 4.  Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants.

Authors:  Cong Sun; Chu Xie; Guo-Long Bu; Lan-Yi Zhong; Mu-Sheng Zeng
Journal:  Signal Transduct Target Ther       Date:  2022-06-28

5.  Deciphering the Impact of Mutations on the Binding Efficacy of SARS-CoV-2 Omicron and Delta Variants With Human ACE2 Receptor.

Authors:  Alamgir Khan; Salman Ali Khan; Komal Zia; Mezna Saleh Altowyan; Assem Barakat; Zaheer Ul-Haq
Journal:  Front Chem       Date:  2022-06-08       Impact factor: 5.545

6.  Culturing Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) for Diagnosis and Genome Sequencing.

Authors:  Zhiqi Zeng; Hua Guo; Liping Chen; Zhengshi Lin; Wenda Guan; Yutao Wang; Haiming Jiang; Xiao Wu; Yong Yin; Zelong Gao; Canxiong Chen; Zifeng Yang
Journal:  Lab Med       Date:  2022-06-17

7.  Receptor binding domain of SARS-CoV-2 from Wuhan strain to Omicron B.1.1.529 attributes increased affinity to variable structures of human ACE2.

Authors:  Shankargouda Patil; Khalid J Alzahrani; Hamsa Jameel Banjer; Ibrahim Faisal Halawani; Hosam Alzahrani; Malik A Altayar; Sarah Albogami; Robert Fua Angeles; Ali Abdel-Halim Abdel-Azim Hassan; Shilpa Bhandi; A Thirumal Raj
Journal:  J Infect Public Health       Date:  2022-06-16       Impact factor: 7.537

8.  Development of a simple genotyping method based on indel mutations to rapidly screen SARS-CoV-2 circulating variants: Delta, Omicron BA.1 and BA.2.

Authors:  Wajdi Ayadi; Awatef Taktak; Saba Gargouri; Fahmi Smaoui; Amel Chtourou; Houda Skouri-Gargouri; Rihab Derbel; Azza Hadj Sassi; Ali Gargouri; Adnene Hammami; Héla Karray-Hakim; Raja Mokdad-Gargouri; Lamia Fki-Berrajah
Journal:  J Virol Methods       Date:  2022-06-18       Impact factor: 2.623

9.  Amomum tsao-ko essential oil, a novel anti-COVID-19 Omicron spike protein natural products: A computational study.

Authors:  Ju-Zhao Liu; Hong-Chang Lyu; Yu-Jie Fu; Qi Cui
Journal:  Arab J Chem       Date:  2022-04-18       Impact factor: 6.212

10.  An exploratory study on the propagation of SARS-CoV-2 variants: Omicron is the most predominant variant.

Authors:  Muthusami Rathinasamy; Saritha Kandhasamy
Journal:  J Med Virol       Date:  2022-02-26       Impact factor: 20.693
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.